Biologic Therapy
‘Strong data’ support ESK-001’s potential as oral treatment for plaque psoriasis
ORLANDO — Patients treated with ESK-001 for moderate to severe plaque psoriasis experienced positive clinical responses through a year, according to a presentation at the American Academy of Dermatology Annual Meeting.
Adherence to asthma biologics varies by therapy given, tends to be low
SAN DIEGO — Across six asthma biologics, adherence differed by the therapy given and was often low or irregular based on three adherence measures, according to a presentation here.
After 25 years of biologics in juvenile arthritis, new approaches are ‘not being explored’
The approval of etanercept for juvenile idiopathic arthritis in 1999 heralded a new era for children with arthritis. However, despite subsequent approvals for JIA, many patients with other types of childhood arthritis remain without options.
Rezpegaldesleukin gets FDA fast track designation for atopic dermatitis
The FDA has granted a fast track designation to rezpegaldesleukin for treating patients aged 12 years and older with moderate to severe atopic dermatitis that topical therapies have not adequately controlled, according to a press release.
Systemic Therapies
Novel biologic scaffold-anchor may not improve rotator cuff healing vs. standard anchor
Published results showed the use of a novel bioresorbable scaffold-anchor to augment healing after rotator cuff repair may not yield clinically superior outcomes compared with a standard anchor.
Uptake of Benlysta, Saphnelo signal ‘exciting time’ for ‘lupologists’
Uptake of belimumab continues to outpace the use of anifrolumab among clinicians managing patients with systemic lupus erythematosus, according to a survey conducted by Spherix Global Insights.
Wrapped up 2024: Healio revisits a year in orthobiologics
Healio highlights the most-read research, topics and news in orthobiologics in 2024.
Orthobiologics may be effective alternative to exercise therapy after rotator cuff tear
Percutaneous orthobiologic treatment may be an effective alternative to home exercise therapy for treatment of rotator cuff tears, according to results published in BMC Musculoskeletal Disorders.
AGA updates living guideline on pharmacological management of moderate to severe UC
In light of a “significant expansion in the therapeutic armamentarium” for moderate to severe ulcerative colitis, the AGA has released an updated living clinical practice guideline of patient-centered pharmacological interventions.